Fillimited

Fillimited is a declared insider at 6 companies; the most frequent names are 사람인, JW생명과학 and 펌텍코리아. We count 40 filings; the first trade dates from 1 April 2021 and the latest from 12 October 2026.

The open-market side counts 35 purchases for €61.7M alongside 4 sales. The amount is not disclosed for 32 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 14 purchases and 4 sales on the market.

In size, the median ticket on the buying side is €1.9M. Measured against the company's value, the median purchase equals 0.95% of market capitalisation, across 7 purchases where it is known. On 3 out of 35 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 7 purchases with a full 90-day history, the hit rate stands at 29% and the median 90-day move at -7.2%. This is a record of the past, not a forecast.

The latest filing, published on 12 October 2026, reports a transaction in GST. The last insider purchase was made public on 10 July 2026, 100 days ago. Filings reach the DART (FSS) feed a median of 13 days after the trade. That lag is the time during which only the insider knows about the trade. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.